Evaluation of the effect of vitamin E in women with urinary tract infectio

Phase 3

Recruiting

• Conditions: ower urinary tract infection.; Urinary tract infection, site not specified; N39.0

• Registration Number: IRCT20210617051604N1
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Women over 18 years
At least three symptoms including frequency, urgency (urgent need to urinate), dysuria, hematuria, and suprapubic pain

Exclusion Criteria

History of allergy or intolerance to vitamin E
Peptic ulcer bleeding
Hemophilia
Use of antiplatelet and anticoagulant drugs
Urinary tract obstruction and urological abnormalities
History of renal abscess
Diabetes mellitus
Taking antibiotics in the previous two days
Catheterization two weeks ago
History of hospitalization or catheter in two weeks ago
Kidney stones
Pregnancy and lactation
Immune deficiency (Patients with HIV, etc)
Vitamin K deficiency
Liver and renal failure
Candidate for surgery
Flank pain, fever above 37.7 ° C, fever and chills, feeling ill and tired or other evidence of systemic infection, CVA tenderness, symptoms of vaginitis (itching and vaginal discharge)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency. Timepoint: 3 to 5 days after starting treatment. Method of measurement: Questionnaire.;Dysuria. Timepoint: 3 to 5 days after starting treatment. Method of measurement: Questionnaire.;Urgency. Timepoint: 3 to 5 days after starting treatment. Method of measurement: Questionnaire.;Recurrence rate of urinary tract infection. Timepoint: 3 and 6 months after starting treatment. Method of measurement: Questionnaire.;Mean recovery time. Timepoint: During study. Method of measurement: Questionnaire.